InvestorsObserver
×
News Home

Is Spectrum Pharmaceuticals Inc (SPPI) Stock About to Get Hot Monday?

Monday, March 27, 2023 03:27 PM | InvestorsObserver Analysts

Mentioned in this article

Is Spectrum Pharmaceuticals Inc (SPPI) Stock About to Get Hot Monday?

Spectrum Pharmaceuticals Inc (SPPI) stock has fallen 15.00% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,bearish
Spectrum Pharmaceuticals Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on SPPI!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With SPPI Stock Today?

Spectrum Pharmaceuticals Inc (SPPI) stock is trading at $0.68 as of 3:24 PM on Monday, Mar 27, a rise of $0.01, or 2% from the previous closing price of $0.67. The stock has traded between $0.66 and $0.71 so far today. Volume today is 1,542,117 compared to average volume of 1,771,877. To see InvestorsObserver's Sentiment Score for Spectrum Pharmaceuticals Inc click here.

More About Spectrum Pharmaceuticals Inc

Spectrum Pharmaceuticals Inc operates in the healthcare sector in the United States. It is a biopharmaceutical company with a primary strategy comprised of acquiring, developing and commercializing novel and targeted oncology therapies. Eflapegrastim and Poziotinib are it's current drugs in last stage development. Eflapegrastim is a novel long-acting granulocyte colony-stimulating factor ("G-CSF") for the treatment of chemotherapy-induced neutropenia and Poziotinib is a novel irreversible tyrosine kinase inhibitor under investigation for non-small cell lung cancer ("NSCLC") tumors with various mutations. Click Here to get the full Stock Report for Spectrum Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App